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Abstract The content of phenolic compounds (TPC) and
glucans, as well as the effectiveness of antiproliferative and
antioxidant activity of differently processed Ganoderma
lucidum ethanol extracts were determined and compared.
The content of glucans (total, a- and b-) strongly depended
on the extraction time and particle size, but only interaction
of these parameters influenced the TPC. Gallic acid,
quercetin, trans-cinnamic acid, kaempferol, hesperetin and
naringenin were detected in extracts by HPLC–DAD. The
most abundant phenols were hesperetin (1.875–3.222 lg/g)
and naringenin (1.235–2.856 lg/g). The ethanol extracts
exhibited noteworthy antioxidant activity, but the signifi-
cant amount of phenolic compounds was strongly linked to
polysaccharides, and hence reduced their antioxidant
capacity. The results of the antiproliferative activity
in vitro showed that the analyzed extracts were the most
effective against HeLa cells. Significant correlations were
observed between the antiproliferative effect and the TPC/
glucan content of extracts.
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Introduction
The increasing demand for the natural drug and food
supplements is expected to further increase the growth of
mushrooms that have been recognized as one of the most
potential raw materials in the production of functional food
and drinks. Mushrooms have been widely used for cen-
turies in traditional Chinese medicine as panacea and cure
in treatment of many diseases. Recent studies confirmed
that they represent an unlimited source of pharmaceutical
substances with potent and unique properties. Non-edible
mushrooms with coarse texture and therapeutic effects
represent medicinal mushrooms (Wasser 2005). During the
past decades, Ganoderma lucidum is recognizable as one of
the most important medicinal mushroom, which contains
highly bioactive secondary metabolite with an enormous
variety of chemical structures. These bioactive chemical
molecules extracted from G. lucidum fruit body, mycelium
and spores include phenols, terpenoids, steroids, nucleo-
tides, as well as their derivatives—glycoproteins and
polysaccharides (Galor et al. 2011; Yuen and Gohel 2005).
Polysaccharides and triterpenoids are considered as
important marker components with beneficial properties in
the treatment of various diseases, but recent studies also
recognize the importance of phenolic compounds (Ferreira
et al. 2009; Yuen and Gohel 2005). Many compounds of
crude extract have a synergistic effect, resulting to an
increase in biological activity of the extract (Liu et al.
2002).
Medicinal mushrooms synthesize various antibacterial,
antifungal and antiviral substances, which can be purified
and applied in clinical practice. They are also shown
antitumor effects in animals and humans, which led to
introducing them into the phase I, II, and III clinical trials
(Wasser 2010). Thus, recent research studies showed that
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Ganoderma lucidum extracts possess significant anticancer
potential (Cao and Lin 2006; Chen et al. 2010). The sub-
stances responsible for chemopreventive and/or tumorici-
dal activity of Ganoderma genus are polysaccharides and
triterpenes, but their capacity highly depends on the
extraction and purification methods (Wasser 2010; Yuen
and Gohel 2005).
In general, a wide range of extraction and isolation
procedures have been set up for the extraction of relevant
bioactive compounds from Ganoderma fruit body, espe-
cially polysaccharides (Ferreira et al. 2015). It is well
established that Ganoderma lucidum contains the diverse
structure of bioactive polysaccharides, mostly in the form
of glucans with different types of glycosidic linkages, such
as (1–3), (1–6)-b-glucans and (1–3)-a-glucans (Wasser
2002). It was previously reported that polysaccharides with
cytotoxic activity were mainly in the form of b-glucans
(Silva 2003).
In addition to anticancer effects of G. lucidum, as the
most investigated, recent studies have focused also on the
evaluation of its antioxidant effects. There are many
reports regarding antioxidant properties of Ganoderma
lucidum, not only methanol (Heleno et al. 2012; Karaman
et al. 2010; Kim et al. 2008) and ethanol extracts (Ćilardžić
et al. 2014; Sheikh et al. 2014), but also aqueous extracts
(Heleno et al. 2012; Kozarski et al. 2011, 2012). The type
of solvent has a significant influence on the dynamic of
extraction process and determinate the chemical composi-
tion of extract. Thus, the extraction parameters can be
optimized in order to obtain an extract with desired
bioactive effects. Some previous studies showed that
methanol extracts of G. lucidum have higher antioxidant
potential compared with water extracts (Rawat et al. 2013).
However, the methanol is highly toxic and is not a suit-
able solvent for the extracts with application in food
industry (or methanol must be removed before use in food
production).
Despite the fact that knowledge about chemical com-
position of Ganoderma lucidum is very important, the data
about optimal extraction conditions and compounds which
mostly contribute to the antioxidant activity of extracts is
limited. Although G. lucidum represents poor source of
phenolic compounds, some investigations reported that
these compounds provide the greatest contribution to the
antioxidant activity of its extracts (Ćilardžić et al. 2014;
Saltarelli et al. 2009). The major flavonoids with effective
antioxidant activity in the ethanol extract from mycelia of
G. lucidum are quercetin, myricetin, and morin (Saltarelli
et al. 2015).
The aim of the present work was to investigate the
influences of particle size and extraction time on the con-
tent of phenolic compounds and glucans of Ganoderma
lucidum ethanol extracts. Also, to examine the influence of
chemical composition on effectiveness of the antiprolifer-




Gallic acid (GA), Folin–Ciocalteu’s phenol reagent,
hydrochloric acid, sodium acetate trihydrate, glacial acetic
acid and sodium carbonate were purchased from Merck
(Darmstadt, Germany). 2,4,6-Trypyridyl-s-triazine-s-tri-
azine (TPTZ), ferric chloride hexahydrate, 2,2-diphenyl-1-
picrylhydrazyl (DPPH), 6-hydroxy-2,5,7,8 tetram-
ethylchroman-2-carboxylicacid (Trolox), sodium dihydro-
gen phosphate, sodium hydrogen phosphate, sodium
chloride, 2,2-azinobis (3-ethylbenzothiazoline-6-sulphonic
acid) diammonium salt (ABTS), potassium persulfate and
phenolic standards rutin, naringenin, chlorogenic acid,
trans-cinnamic acid, quercetin, p-coumaric acid, caffeic
acid, p-hydroxybenzoic acid, syringic acid, vanillic acid,
resveratrol and kaempferol were purchased from Sigma-
Aldrich (Steinheim, Germany), while hesperetin and cate-
hin were purchased from Fluka (Steinheim, Germany).
Benzoic acid was obtained from Lachnema (Nerastovice,
Czech Republic) and gallic acid from Alfa Aesar (Lan-
caster, Great Britain). The purities of standards were up to
99%. The solvents used were of analytical grade
dimethylsulfoxide J.T. Baker (NJ, USA), glacial acetic acid
POCH (Gliwice, Poland) and acetonitril HPLC grade J.T.
Baker (NJ, USA). An analytical mushroom b-glucan kit
was obtained from Megazyme Int. (Wicklow, Ireland).
Sample preparations
Ganoderma lucidum (W. Curt.: Fr.) P. Karst. fruiting
bodies were obtained from Jingsu Alphay Bio-Tech, Co.
Ltd. (PR Chine). Fruit bodies were separated from spores
using brushes and then air-dried at 40 C to constant mass.
The fruit bodies were prepared for extraction by cutting
into pieces (about 1 cm) and by grounding into fine parti-
cles. The average particle size of ground fungi was mea-
sured on sieve shaker Analysette 3 Pro (Fritsch, Idar –
Oberstein, Germany). The average milled particle size was
0.13 mm. Six samples of ethanol extracts (E1–E6) were
produced in the experiment. The production parameters are
presented in Table 1. Fragmented mushroom sample (40 g)
was extracted using 60% ethanol (1000 ml), at 25 C,
stirred using a rotary shaker (120 rpm). Liquid phase (ex-
tracts) was separated by filtration through 70 g/m3 filter
paper. After filtration, the solvent was partially removed by
vacuum evaporation (Rotavapor R-200/205, Buchi,
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Labortechnik AG, Meiersegg strasse, Flawil, Switzerland)
and its complete removal was performed by lyophilisation
(Modulyo D-230, Thermo Savant, Holbrook, NY, USA).
Determination of total phenolics and antioxidant
capacity
Determination of total phenolic content (TPC) in the
samples of G. lucidum extract was conducted by the Folin-
Ciocalteu method described by Singleton and Rossi (1965).
For the determination of antioxidative characteristics of
samples, the DPPH, Ferric ion Reducing Antioxidant
Power (FRAP) and Trolox equivalent antioxidant capacity
(TEAC) methods were used. DPPH-reducing activity was
evaluated following modified procedure described by
Kaneda et al. (1995). FRAP assay was performed accord-
ing to the procedure by Benzie and Strain (1996). The
TEAC assay was conducted according to the procedure
described by Re et al. (1999).
HPLC analyses of phenolic compounds
Phenolic compounds were determined by the HPLC
method using an Agilent 1100 Series liquid chromatograph
(Palo Alto, CA, USA) equipped with UV/DAD detector.
Chromatographic separation was performed on Poroshell
120 EC-C18 (4.6 9 100 mm 2.7 lm) column. The solvent
system had a constant flow rate of 1.0 ml/min. The mobile
phase was distilled water with 0.1% glacial acetic acid
(solvent A) and acetonitrile with 0.1% glacial acetic acid
(solvent B). The gradient was: 0–3.25 min, 8–10%B;
3.25–8 min, 10–12%B; 8–15, 12–25%B; 15–15.8 min,
25–30%B; 15.8–25 min, 30–90%B; 25–25.4 min,
90–100%B; 25.4–30 min, 100%B. Injection volume was
5 ll and temperature was kept constant at 25 C. Detection
wavelengths were chosen according to absorption maxi-
mum of analyzed phenolic compounds and included
225 nm (vanillic acid, benzoic acid), 280 nm (gallic acid,
4-hydroxybenzoic acid, catehin, syringic acid, trans-cin-
namic acid, hesperetin, naringenin), 305 nm (coumaric
acid, resveratrol), 330 nm (chlorogenic acid, caffeic acid)
and 360 nm (rutin, quercetin, kaempferol). Quantification
was performed by external standard method. The standard
stock solutions (1, 2.5, 5, 10, 15, 25 mg/l) were made with
dimethylsulfoxide (DMSO). All standard calibration curves
showed high degrees of linearity (r2[ 0.99). Samples were
filtered through 0.45 lm filter prior to direct injection in
HPLC.
Measurement of glucan content
The contents of total and a-glucans were determined in
the polysaccharide extracts using the Mushroom and
Yeast b-glucan Assay Procedure (Megazyme Int.)
according to the method describe by authors (Kozarski
et al. 2012). The b-glucan content was calculated by
subtracting the a-glucan from the total glucan content. All
values of glucan contents were expressed as g/100 g of a
dry weight (DW) of the extracts. Results were calculated
with the Megazym program Mega-CalcTM.
Cell lines and culture conditions
Human cervical carcinoma (HeLa), human alveolar basal
adenocarcinoma (A549) and human colon carcinoma
(LS174) cell lines were maintained as monolayer cultures
in the Roswell Park Memorial Institute (RPMI) 1640
nutrient medium (Sigma Chemicals Co, Saint Louis, Mo,
USA). The endothelial cell line EA.hy 926 (permanent
human cell line derived by fusing human umbilical vein
endothelial cells—HUVEC, with human lung adenocarci-
noma epithelial cells—A549), was maintained in the
nutrient medium, Dulbecco’s Modified Eagle Medium
(DMEM) (Sigma Aldrich, Steinheim, Germany). Nutrient
mediums were prepared in sterile ionized water, supple-
mented with penicillin (192 U/ml), streptomycin (200 lg/
ml), 4-(2-hydroxyethyl)piperazine-1-ethanesulfonic acid
(HEPES) (25 mM), L-glutamine (3 mM), 10% of heat-in-
activated fetal calf serum (FCS) (pH 7.2) and D-glucose
(4.5 g/l). The cells were grown at 37 C in 5% CO2 and
humidified air atmosphere.
MTT assay
Antiproliferative activity of the investigated extracts was
determined using 3-(4,5-dymethylthiazol-yl)-2,5-diphenyl-
tetrazolium bromide (MTT, Sigma-Aldrich, Steinheim,
Germany) assay, according to the procedure described
previously (Rakić et al. 2012; Supino 1995).
Precisely, cells were seeded into 96-well cell culture
plates (Thermo Scientific NuncTM, Sigma-Aldrich, Stein-
heim, Germany), at a cell density of 4000 cells/well (HeLa
and Ea.hy 926), 6000 cells/well (A549), and 10,000 cells/
well (LS174) in 100 ll of culture medium. After 24 h of
growth, cells were exposed to the serial dilutions of the
tested extracts. The investigated compounds were dis-
solved in DMSO at a concentration of 50 mg/ml as stock
solution, and prior the use diluted with nutrient medium to
the desired final concentrations (in range up to 500 lg/ml).
Table 1 The parameters of extract production
Parameters E1 E2 E3 E4 E5 E6
Extraction time (days) 15 15 30 30 1 1
Particles size (mm) 10 0.13 10 0.13 10 0.13
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Each concentration was tested in triplicates. After incuba-
tion periods of 24 or 48 h, 20 ll of MTT solution (5 mg/
mL in phosphate buffer solution, pH 7.2) were added to
each well. Samples were incubated for 4 h at 37 C, with
5% CO2 in a humidified atmosphere. Formazan crystals
were dissolved in 100 ll of 10% sodium dodecyl sulfate
(SDS). Absorbances were recorded after 24 h, on an
enzyme-linked immune sorbent assay (ELISA) reader
(Thermo Labsystems Multiskan EX 200–240 V, Termo
Fisher Scientific Oy, Vanta, Finland), at the wavelength of
570 nm. IC50 values (lM), were determined from the cell
survival diagrams. The percentages of surviving cells rel-
ative to untreated controls were determined. The IC50
value, defined as the concentration of the compound
causing 50% cell growth inhibition, was estimated from the
dose–response curves.
Statistical analyses
All measurements were done in triplicate and data were
expressed as mean value ± standard deviation (SD). The
experimental data were subjected to the analysis of variance
(ANOVA).Analysiswas conducted in a factorial arrangement
where time extraction and concentration of addedG. lucidum
were analyzed factors. Tukey’s test was used to determine
difference (p B 0.01) between the mean values. The corre-
lation between TPC, glucans (total, a- and b-), antioxidant
activity and antiproliferative effect was also determined. All
statistical analyses were performed using statistical program
Statistica 12 (Statsoft Inc., Tulsa, Oklahoma, USA).
Results and discussion
Phenolic compounds analyses
The total phenolic content (TPC) of samples and their
composition are shown in Table 2. Investigated factors
(particle size and extraction time) had no significant
influence on TPC independently. However, the interaction
of these two factors had highly significant effect on TPC
(F = 20.45; p = 0.00), which indicates that particle size
and extraction time affect only in conjunction.
Considering tested samples, the TPC were ranged from
8.6 ± 1.0 (E4) to 13.9 ± 0.3 (E6) g/100 g gallic acid
equivalents (GAE) (Table 2). The transfer of soluble
compounds from the interior of the small fungi particles to
the alcohol-water solution was intensive, and extraction
period was shorter. After the complete extraction of phe-
nolic compounds, longer extraction period allowed them to
degrade or react with other substances in solution. Hence,
the content of total phenolic compounds was decreased
with the extended extraction period. In the case of chopped
G. lucidum samples, transfer of the phenolic compounds
from the inside of the particles was slower, but their con-
centration was increased by longer extraction period.
In the previous study, TPC of hot water extracts of G.
lucidum and G. appalantum was found to be 3.3 and 4.7 g/
100 g, respectively (Kozarski et al. 2012). In the research
of TPC in the purified phenolic and polysaccharide extracts
of Ganoderma lucidum fruit body and spore, the reported
values were 2.86, 5.5, 1.5 and 4.3 g/100 g GAE, respec-
tively (Heleno et al. 2012). TPC of ethanol extract of wild
G. lucidum collected from Madhya Pradesh (Central India)
was 7.14 ± 0.09 g/100 g GAE (Sheikh et al. 2014). TPC
of ethanol extracts was significantly higher than reported in
mentioned studies. The obtained results showed that the
extraction procedure had a significant effect on the TPC,
wherein the highest concentration of phenolic compounds
were achieved in extracts produced from ground mushroom
with extraction time of 24 h.
The ethanol extracts of G. lucidum were analyzed by
HPLC–DAD and the results are presented in Table 2.
Detected phenolic compounds can be classified into phenolic
acids (gallic acid and trans-cinnamic acid) and flavonoids
(quercetin, kaempferol, hesperetin and naringenin).
Table 2 Total phenolic content (TPC) and composition of phenolic compounds in ethanol extracts of Ganoderma lucidum
Compounds Samples (lg/g)
E1 E2 E3 E4 E5 E6
TPC (g/100 g GAE) 9.4 ± 0.2a 11.8 ± 0.3a,b 13.7 ± 0.4b 8.6 ± 1.0a 8.8 ± 1.2a 13.9 ± 0.3b
Gallic acid 0.142 ± 0.003a 0.915 ± 0.001b nd. 0.892 ± 0.002c nd. 1.016 ± 0.004d
Trans-cinnamic acid 0.054 ± 0.002a 0.084 ± 0.001b 0.046 ± 0.000c 0.061 ± 0.000d 0.060 ± 0.003d 0.104 ± 0.002e
Quercetin nd. 0.798 ± 0.001a nd. 0.844 ± 0.001b 0.124 ± 0.001c 0.968 ± 0.003d
Kaempferol 0.598 ± 0.002a 0.871 ± 0.004b 0.584 ± 0.001c 0.860 ± 0.000d 0.657 ± 0.002e 0.918 ± 0.001f
Hesperetin 1.875 ± 0.001a 2.569 ± 0.003b 1.949 ± 0.000c 3.218 ± 0.000d 2.171 ± 0.001e 3.222 ± 0.004d
Naringenin 2.543 ± 0.002a 1.578 ± 0.001b 2.562 ± 0.002c 1.235 ± 0.002d 2.856 ± 0.002e 2.812 ± 0.003f
nd. not detected
Different letters in same row denote a significant difference according to Tuckey’s test, at p\ 0.01
J Food Sci Technol (April 2017) 54(5):1312–1320 1315
123
The composition and content of individual phenolic
compounds were significantly different between the
extracts from minced and chopped mushrooms. The
minced mushroom particles released higher content of
phenolic compounds than the cut particles, which was
expected in accordance with the literature data (Luthria
2008). However, an exception was naringenin, whose
concentration was higher in samples from chopped mush-
room. The reason for that is not entirely clear, but one of
possible explanation is the following: the highest concen-
tration of all determined individual phenolic compounds
was after 24 h of extraction, wherein at that moment the
naringenin concentration in the samples E5 and E6 (pro-
duced from milled and chopped mushroom, respectively)
was very similar. During the prolonged extraction, con-
centration of analyzed individual phenols was decreased
due to oxidation and/or reactions with other compounds in
solution.
Although, the phenolic compounds represent one of
the most important groups with bioactive effect in
Ganoderma lucidum, only few studies were conducted to
determine the content and composition of its phenolic
compounds. Kim et al. (2008) studied the content of
phenolic compounds in Ganoderma lucidum cultivated
in Korea and reported total phenol content 162 lg/g dw.
Detected following phenolic compounds were gallic
acid, pyrogallol, 5-sulfosalicylic acid, protocatechuic
acid, catechin, benzoic acid, myricetin, quercetin,
kaempferol, hesperetin, formononetin and biochanin.
Furthermore, the phenolic compounds were evaluated in
phenol extracts, made from fruiting body, spores and
mycelium produced in different media (Heleno et al.
2012). Total phenol content in phenol extracts was
ranged from 2.5 to 12.3 lg/g, and detected phenolic
compounds in extracts were the p-hydroxybenzoic, p-
coumaric and cinnamic acid. The flavonoids in the
ethanolic extracts from mycelia of Ganoderma lucidum
strains Gl-4 and Gl-5 were analyzed, and quercetin,
myricetin, and morin were identified (Saltarelli et al.
2015). Gallic acid (1103 lg/g) was the only detected
phenolic compound in methanol extract of wild growing
Ganoderma lucidum collected from Fruška gora, Serbia.
However, its content was significantly higher than
described by the other studies (Karaman et al. 2010).
Our research showed greater TPC concentration in
analyzed ethanol extracts comparing to previously
reported results (Heleno et al. 2012; Sheikh et al. 2014).
It is well known that gallic acid is compound with strong
antioxidant activity (Rice-Evans et al. 1996), and its
highest concentration was found in sample E6. The most
abundant phenols in all samples were hesperetin and
naringenin, while trans-cinnamic acid was present in
very low concentration.
Antioxidant activity
Many different in vitro assays are used for the determina-
tion of antioxidant capacity, since there is not defined
standard method. Three methods, the DPPH, Ferric ion
reducing antioxidant power (FRAP) and Trolox equivalent
antioxidant capacity (TEAC), were selected to analyze the
samples.
The all produced extracts showed significant antioxidant
capacity (Table 3). In contrast to the TPC, antioxidant
activity was significantly depended on the extraction time
and particle size, as well as their mutual interaction.
The results of antioxidant assays clearly revealed that
the largest amount of soluble compounds with antioxi-
dant capacity was extracted after 1 day from the milled
particles. Thus, the extraction process was finished after
1 day and extended extraction may adversely influence
the quality of extracts due to degradation of soluble
bioactive compounds. Unlike the milled particles,
dynamic of extraction of chopped mushroom was dif-
ferent, where the extraction process was finished after
15 days. Based on the results of antioxidant capacity,
extraction time is inversely proportional to the size of
the particles. However, the increase in the antioxidant
capacity of extracts due to the reduction of particle size
or extension of the extraction time is limited; for each
particle size, optimum extraction time should be
determined.
The ethanol extracts had significantly higher antioxidant
activity (4.32–6.65 FRAP units and 2.52–6.00 mmol Tro-
lox Equivalent) compared with special brandy produced
with same amount of G. lucidum (40 g/L) (0.432 FRAP
units and 1.043 mmol Trolox Equivalent) (Pecić et al.
2016). The main reason for such a big difference is the fact
that the evaporation of solvent and concentration of
bioactive compounds significantly affects the increase of
the antioxidant capacity.
Table 3 Antioxidant capacity of Ganoderma lucidum ethanol
extracts evaluated with DPPH, FRAP and TEAC assays
Samples DPPH (mM TE) FRAP (FRAP unit) TEAC (mM TE)
E1 2.08 ± 0.16a,b 4.85 ± 0.10a 3.64 ± 0.06a
E2 2.33 ± 0.14b,c 5.40 ± 0.26b 4.40 ± 0.08b
E3 1.40 ± 0.05a 4.32 ± 0.08c 2.52 ± 0.08c
E4 2.05 ± 0.06a,b 6.46 ± 0.10d 3.78 ± 0.07a
E5 1.81 ± 0.12a,b 4.48 ± 0.06a,c 3.29 ± 0.09d
E6 3.07 ± 0.20c 6.65 ± 0.13d 6.00 ± 0.19e
Different letters in same column denote a significant difference
according to Tuckey’s test, at p\ 0.01
mM TE mM Trolox Equivalent
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Glucan content
The content of glucans (total, a- and b-) was measured
using Megazyme b-glucan assay kit. The results are pre-
sented in Table 4. The results of ANOVA showed that total
glucan contents of ethanol extracts was strongly depended
on the extraction parameters and varied from
9.44 ± 0.03 g/100 g (E6) to 18.55 ± 0.04 g/100 g (E1).
Total glucan content of Ganoderma lucidum hot water
polysaccharide and spore extracts were 47.1 ± 0.6 g/100 g
and 20.8 ± 0.5 g/100 g, respectively (Kozarski et al.
2011, 2012).
The concentration of a-glucans is not negligible and
valued from 5.72 to 17.72%. The percentage of a-glucans
in ethanol extracts was similar with the content in hot water
extracts, but enormously smaller than in spore extract of G.
lucidum (Kozarski et al. 2011).
b-glucan content was determined by subtracting a-glu-
cans from total glucans. The content of b-glucans in
ethanol extracts was from 8.90 ± 0.04 to 15.64 ± 0.01 g/
100 g. The reported amount is much lower than in hot
water Ganoderma lucidum extract 41.4 ± 1.4 g/100 g
(Kozarski et al. 2012). In the other study, b-glucans content
in Ganoderma lucidum was determined by the enzymatic
HPLC method, and the obtained value was lower
(7.9 ± 0.2 g/100 g) compared to our ethanol extracts (Su
et al. 2016).
The polysaccharides is mainly water-soluble com-
pounds, hence hot water extraction is the most commonly
used procedure for their separation (Ferreira et al. 2015;
Wasser 2002). In our research, 60% v/v ethanol was used
as a solvent for extracts production, and this is the main
reason why is the content of glucans greater in our extracts
compared to purified phenolic extracts (obtained by
extraction with 96% v/v ethanol).
Obtained data indicate that particle size had the impor-
tant effect on the content of a-, b- and the total glucans in
the ethanol extracts. Specifically, increasing the particle
size also increases the amount of glucans in the ethanol
extracts.
Cytotoxicity in cancer cell lines
The antiproliferative activity of Ganoderma extracts (E1-
E6) was evaluated, using colorimetric MTT assay. The
study was performed in several human neoplastic cell lines
(HeLa, A549, LS174) and transformed endothelial cell line
EA.hy 926. The results are summarized in Table 5 in terms
of IC50 values with their standard deviations for the 24 and
48 h incubation periods.
The obtained cytotoxicity results revealed that extracts
E1-E6 mostly exhibited antiproliferative activity against all
cell lines used in range of concentrations up to 500 lg/ml.
It is shown that the analyzed extracts were most effective
against HeLa—human cervical carcinoma, while the least
sensitive was LS174—colon carcinoma cell line. The
extract E4 expressing the highest antiproliferative activity
against HeLa, Ea.hy 26 and LS174 cell, contained the
Table 4 a-, b- and total glucans content in G. lucidum extracts
Glucan content (g/100 g)
Total a b
E1 18.55 ± 0.04a 2.91 ± 0.06a 15.64 ± 0.01a
E2 15.81 ± 0.04b 2.43 ± 0.04a 13.38 ± 0.01b
E3 16.53 ± 0.07c 2.93 ± 0.03b 13.62 ± 0.02c
E4 13.42 ± 0.05d 1.79 ± 0.04c 11.63 ± 0.03d
E5 14.72 ± 0.03e 1.68 ± 0.02d 13.03 ± 0.05e
E6 9.44 ± 0.03f 0.54 ± 0.01e 8.90 ± 0.04f
Different letters in same column denote a significant difference
according to Tuckey’s test, at p\ 0.01
Table 5 Results of the MTT assay presented as IC50 values obtained after 24 and 48 h treatments
Cell line
complex
IC50 ± SD (lg/ml)
HeLa A549 EA.hy 926 LS174
24 h 48 h 24 h 48 h 24 h 48 h 24 h 48 h
E1 357.6 ± 30.9a 209.5 ± 0.6a [500a 459.9 ± 1.8a 484.6 ± 6.2a 282.8 ± 9.4a 394.5 ± 8.3a 390.8 ± 9.1a
E2 364.8 ± 1.5a 244.3 ± 3.7b 375.1 ± 14.1b 290.9 ± 15.5b 385.3 ± 25.7b 242.5 ± 5.2b [500b 342.3 ± 1.7b
E3 [500b 391.2 ± 14.8c [500a [500c 450.7 ± 31.7a,c 370.1 ± 4.1c [500b [500c
E4 223.1 ± 6.9c 119.3 ± 1.0d [500a 344.8 ± 7.9d 408.4 ± 13.5b,d 242.8 ± 1.0b 438.3 ± 10.6c 285.3 ± 1.2d
E5 334.7 ± 5.8d 184.7 ± 0.4e [500a 363.5 ± 4.6e 476.2 ± 10.5a,c 450.8 ± 4.2d [500b 412.1 ± 5.4e
E6 394.3 ± 4.5e 335.5 ± 11.5f 400.1 ± 5.5c 197.7 ± 5.4f 442.5 ± 43.3c,d 336.7 ± 19.2c [500b [500c
The sign[ (in front of the maximum value of the concentration) indicates that IC50 value is not reached in the examined range of concentrations
Different letters in same column denote a significant difference according to Tuckey’s test, at p\ 0.01
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smallest amount of TPC (8.6/100 g), but its content of
particular phenolic compounds detected by HPLC was
very high. Considering our results, it can be concluded that
those phenolic compounds also influenced the antiprolif-
erative effect.
Recent study regarding Ganoderma extracts from Ser-
bia exhibited cytotoxic effect on breast and cervical cell
lines, confirming the results we have just reported (Sto-
jković et al. 2014). Ethanol extracts obtained from basid-
iocarps of Ganoderma lucidum cultivated on alternative
and commercial substrate manifested a more powerful
cytotoxic effect against HeLa (38.11–109.04 lg/ml) and
A549 (26.48–167.08 lg/ml) cell lines compared to our
extracts (Ćilardžić et al. 2014). However, it should take
into account that the mentioned cell lines was cultured
with the indicated concentrations of ethanol extracts for a
longer period (72 h). Comparison of the results leads to
the suggestion that there was significant difference
regarding cytotoxicity of the investigated extracts, and that
also cell line and the period of treatment caused significant
antiproliferative differences in vitro.
The cytotoxic effect of Ganoderma lucidum is usually
related with the content of polysaccharides (Liu et al.
2015), but there are also recent studies that have confirmed
the cytotoxic effect of ganoderic acids, which are one of
the most important bioactive compounds in ethanol
extracts (Li et al. 2010).
Correlation between TPC and b-glucans
and antioxidant and antiproliferative activity
of Ganoderma lucidum extracts
The correlations between total phenolic content, antioxi-
dant activity, glucans content (total, a- and b-) and
antiproliferative activity against cell lines (HeLa, A549,
LS174) for all analyzed samples (E1-E6) were calculated
(Table 6). Statistically significant positive correlation was
observed between antiproliferative activity against HeLa
cell line after 48 h treatment and TPC, and antiprolifera-
tive activity against A549 cell line after 48 h treatment and
total glucans. Hence, it can be concluded that phenolic
compounds also affect cytotoxic activity against HeLa cell
line. Also, the strong correlation was found between
antiproliferative activities on cell lines HeLa 24 h, HeLa
48 h and LS147 48 h.
The correlation between the TPC and antioxidant
capacity was not significant, but other bioactive com-
pounds and their interactions had important influence on
the antioxidant activity. The most active sample E6
showed the highest content of phenolic compounds and the
smallest content of total glucans. According to the results,
the content of b-glucans was in negative correlation with
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(rDPPH = -0.674, rFRAP = -0.778, rTEAC = -0.723).
These results indicate that a significant amount of phenolic
compounds in analyzed samples were linked to polysac-
charides, and therefore reduced their activity. This type of
influence of polysaccharides on antioxidant capacity in
polysaccharide extracts was previously confirmed by
Heleno et al. (2012). According to the results, the antiox-
idant assays were not equally sensitive on the component
with the antioxidant capacity. The results of DPPH and
TAEC were in significant correlation.
Conclusion
The results showed that, extraction parameters (extraction
time and particle size) strongly influenced the transfer pro-
cess of chemical compounds from Ganoderma lucidum
particles to the ethanol–water solution, thus determined the
quality and quantity of analyzed compounds. The glucans
content was affected by particle size and extraction time, as
well as their interaction, while the phenolic content was
influenced only by the interaction of these factors. The
profiles of phenolic compounds were different in the ethanol
extracts made with the different particle size. Gallic acid and
quercetine were detected in the all extracts made from
grounded particles, but in the case of the extracts from
chopped mushroom gallic acid was only found in sample
E1, and quercetin in sample E5. The type and quantity of
bioactive compounds affected the antiproliferative and
antioxidative capacity of analyzed ethanol extracts. The
correlation between the TPC and antioxidant capacity was
not significant, and these results suggested that a significant
amount of phenolic compounds were strongly linked to
polysaccharides, and hence their capacity was reduced.
Acknowledgements This work was performed within the framework
of the research Projects Nos. III 46001 and III 41026 supported by the
Ministry of Education, Sciences and Technological Development,
Republic of Serbia.
References
Benzie IFF, Strain JJ (1996) The ferric reducing ability of plasma
(FRAP) as a measure of ‘‘antioxidant power’’: the FRAP assay.
Anal Biochem 239:70–76
Cao QZ, Lin ZB (2006) Ganoderma lucidum polysaccharides peptide
inhibits the growth of vascular endothelial cell and the induction
of VEGF in human lung cancer cell. Life Sci 78:1457–1463
Chen NH, Liu JW, Zhong JJ (2010) Ganoderic acid T inhibits tumor
invasion in vitro and in vivo through inhibition of MMP
expression. Pharmacol Rep 62:157–170
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